A Randomised, Single-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BI 474121 Administered as Oral Solution and Tablets to Healthy Male Subjects (SRD Part), and a Randomised, Open-label, Single-dose, Three-way Cross-over Bioavailability Comparison of BI 474121 as Tablet Versus Oral Solution and Tablet With and Without Food (BA Part)
Latest Information Update: 28 Mar 2024
At a glance
Most Recent Events
- 18 Oct 2022 Results (n=54 from SRD part and n=12 from BA part) assessing safety, tolerability and pharmacokinetics presented at the 35th Annual Congress of the European College of Neuropsychopharmacology
- 12 Apr 2021 Status changed from active, no longer recruiting to completed.
- 10 Mar 2021 Planned End Date changed from 5 Mar 2021 to 18 Mar 2021.